E-mail

E-mail a Wiley Online Library Link

NIGEL D TOUSSAINT, MARCUS BP TAN, KATHY NICHOLLS, ROWAN G WALKER and SOLOMON J COHNEY Low-dose valaciclovir and cytomegalovirus immunoglobulin to prevent cytomegalovirus disease in high-risk renal transplant recipients Nephrology 16

Version of Record online: 13 JUL 2010 | DOI: 10.1111/j.1440-1797.2010.01379.x

This retrospective review assessed the efficacy of a combination of low-dose valaciclovir and intravenous CMV immunoglobulin to prevent CMV disease in CMV-negative recipients of kidneys from CMV-positive donors (D+/R−) showing that low-dose valaciclovir with CMVIg was as efficacious in preventing CMV disease as other published regimens, including those with full-dose valaciclovir and valganciclovir.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH